Roche’s Analyst Event at ASCO 2018
Roche has hosted an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (1 – 5 June 2018).
| Agenda: | |
|---|---|
| Highlights in cancer immunotherapy | Alan Sandler, M.D., a.i. Global Head Oncology, Global Head Lung Cancer Franchise |
| Biomarkers in the era of cancer immunotherapy | Priti S. Hegde, Ph.D., Oncology Biomarker Development |
| Highlights late stage portfolio outside cancer immunotherapy | Sandra Horning, M.D., Chief Medical Officer and Head Global Product Development |
| Oncology strategy and impact on patients | Daniel O’Day, CEO Roche Pharmaceuticals |